KYNTRA BIO, INC. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

KYNTRA BIO, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $6.44 million for the year ending 2025.

  • KYNTRA BIO, INC. showed a decrease of -78.3% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from KYNTRA BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), KYNTRA BIO, INC.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 96.5%.
  • Historical annual values: Fiscal year 2025: $6.44 million | Fiscal year 2024: $29.62 million | Fiscal year 2023: $46.80 million | Fiscal year 2022: $140.73 million | Fiscal year 2021: $235.31 million | Fiscal year 2020: $176.32 million | Fiscal year 2019: $256.58 million | Fiscal year 2018: $212.96 million | Fiscal year 2017: $131.00 million | Fiscal year 2016: $183.19 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: